MTCO2P20

Across TCGA pan-cancer cohorts, MTCO2P20 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MTCO2P20 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MTCO2P20 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO2P20 expression acts as an unfavorable survival marker, although some lineages such as CESC and UCS show a favorable association.

LUAD, ACC, and PCPG are the cancer types where MTCO2P20 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	IV	0.304	0.791	<.001	92	view →
ACC	OS	Tertile	All	0.145	0.705	.002	72	view →
PCPG	DFS	Tertile	All	0.320	0.815	<.001	48	view →
CESC	OS	Tertile	All	0.962	0.843	.003	42	view →
UCS	DFS	Tertile	All	0.444	0.179	.014	28	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	27	view →
LGG	OS	Quartile	All	0.352	0.478	.003	26	view →
COAD	OS	Tertile	IV	0.183	0.670	.003	18	view →
ESCA	DFS	Quartile	III,IV	0.567	0.244	.011	16	view →
MESO	OS	Tertile	IV	0.266	0.608	.044	9	view →
OV	OS	Quartile	IV	0.539	0.803	.010	6	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MTCO2P20–LUAD (OS)

Open the LUAD breakdown →